These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6576910

  • 1. In vitro drug sensitivity studies of CFUc in chronic myelocytic leukemia: I. Suicide indices and busulfan sensitivity determinations during the chronic phase.
    Preisler HD, Kirshner J.
    Exp Hematol; 1983 Aug; 11(7):618-25. PubMed ID: 6576910
    [Abstract] [Full Text] [Related]

  • 2. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W.
    Acta Med Austriaca Suppl; 1981 Aug; 21():1-20. PubMed ID: 6949436
    [Abstract] [Full Text] [Related]

  • 3. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K, Preisler HD, Costanzo C, Miura Y.
    Cancer Res; 1983 Dec; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [Abstract] [Full Text] [Related]

  • 4. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC, Huxol H, Müller R, Speck B, Nissen C.
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [Abstract] [Full Text] [Related]

  • 5. In vitro drug sensitivity studies of colony-forming units in culture in chronic myelocytic leukemia: lack of specificity between chronic-phase patients and normal donors.
    Kirshner J, Preisler HD.
    Cancer Res; 1983 Dec; 43(12 Pt 1):6094-5. PubMed ID: 6580067
    [Abstract] [Full Text] [Related]

  • 6. Lack of relationship between in vitro cell measurements and response to busulfan in chronic myelocytic leukemia.
    Kirshner J, Preisler HD, Raza A.
    Am J Hematol; 1985 Feb; 18(2):191-200. PubMed ID: 3855599
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of myeloid progenitor cells in healthy subjects and patients with chronic myeloid leukemia to chemotherapeutic agents.
    Spiro TE, Mattelaer MA, Efira A, Stryckmans P.
    J Natl Cancer Inst; 1981 Jun; 66(6):1053-9. PubMed ID: 6941040
    [Abstract] [Full Text] [Related]

  • 8. [Study of colony forming cells and aggregates (CFCA) in vitro in blood and bone marrow of patients with chronic myeloid leukemia: simplified bovine serum albumin gradient centrifugation].
    Berthier R, Douady F, Marcille G, Sotto JJ, Schaerer R, Hollard D.
    Nouv Rev Fr Hematol; 1975 Jun; 15(3):365-74. PubMed ID: 128737
    [Abstract] [Full Text] [Related]

  • 9. Circulating colony-forming cells in different stages of chronic myelocytic leukemia.
    Leong SS, Sokal JE, Gomez GA, Horoszewicz JS.
    Cancer Res; 1979 Jul; 39(7 Pt 1):2704-10. PubMed ID: 286638
    [Abstract] [Full Text] [Related]

  • 10. [Characteristics of clonal evolution in patients with myelocytic leukemia].
    Petukhov VI, Grasmane DV, Bondare DK, Baravika IIa, Medne IT.
    Ter Arkh; 1984 Jul; 56(6):53-8. PubMed ID: 6591505
    [Abstract] [Full Text] [Related]

  • 11. Myeloid colony-forming cell kinetics in man.
    Koeffler HP, Gale RP, Golde DW.
    Exp Hematol; 1980 Mar; 8(3):271-7. PubMed ID: 7007065
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent.
    Spiro TE, Socquet M, Delforge A, Stryckmans P.
    J Natl Cancer Inst; 1981 Apr; 66(4):615-8. PubMed ID: 6939909
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia.
    Pejsa V, Kusec R, Petrovecki M, Jaksic O, Jaksic B, Boranic M.
    Haematologica; 2003 Dec; 88(12):1429-31. PubMed ID: 14688001
    [No Abstract] [Full Text] [Related]

  • 14. Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay.
    Swart K, Hagemeijer A, Löwenberg B.
    Exp Hematol; 1981 Jul; 9(6):588-94. PubMed ID: 6943037
    [Abstract] [Full Text] [Related]

  • 15. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A, Olofsson T.
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [Abstract] [Full Text] [Related]

  • 16. In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease.
    Shih LY, Chiu WF, Dunn P, Liaw SJ.
    Blut; 1988 Sep; 57(3):125-30. PubMed ID: 3166388
    [Abstract] [Full Text] [Related]

  • 17. In vitro granulopoiesis in oligoblastic leukaemia: prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture.
    Berthier R, Douady F, Metral J, Newton I, Schweitzer A, Hollard D.
    Biomedicine; 1979 Dec; 30(6):305-11. PubMed ID: 526532
    [Abstract] [Full Text] [Related]

  • 18. The myeloid progenitor cell: a parallel study of subpopulations in human marrow and peripheral blood.
    Verma DS, Spitzer G, Zander AR, Fisher R, McCredie KB, Dicke KA.
    Exp Hematol; 1980 Jan; 8(1):32-43. PubMed ID: 6967823
    [Abstract] [Full Text] [Related]

  • 19. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapy of chronic myelocytic leukemia.
    Galton DA.
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.